Litcius/Paper detail

Proof of principle study of sequential combination atezolizumab and Vigil in relapsed ovarian cancer

Rodney P. Rocconi, Erin Stevens, Justin Bottsford-Miller, Sharad Ghamande, Jeffrey Elder, Leslie DeMars, Adnan Munkarah, Phylicia Aaron, Laura Stanbery, Gladice Wallraven, Ernest Bognar, Meghan Manley, Staci Horvath, Luisa Manning, Adam Walter, Evanthia Galanis, Thomas J. Herzog, Bradley J. Monk, Robert L. Coleman, John Nemunaitis

2021Cancer Gene Therapy23 citationsDOI

Topics & Concepts

VigilAtezolizumabMedicineInternal medicineAdverse effectOncologyCancerGastroenterologyImmunotherapyPembrolizumabHistoryArchaeologyCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesOvarian cancer diagnosis and treatment
Proof of principle study of sequential combination atezolizumab and Vigil in relapsed ovarian cancer | Litcius